Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 4
2010 1
2011 2
2012 3
2014 1
2015 1
2016 1
2017 2
2018 2
2019 3
2020 1
2021 4
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma.
Davern M, Gaughan C, O' Connell F, Moran B, Mylod E, Sheppard AD, Ramjit S, Yun-Tong Kung J, Phelan JJ, Davey MG, Ryan EJ, Butler C, Quinn L, Howard C, Tone E, Phoenix E, Butt WT, Lynam-Lennon N, Maher SG, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, Donlon NE. Davern M, et al. Among authors: maher sg. Front Immunol. 2023 Jun 9;14:1150754. doi: 10.3389/fimmu.2023.1150754. eCollection 2023. Front Immunol. 2023. PMID: 37359545 Free PMC article.
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy.
Davern M, Donlon NE, Sheppard AS, Majcher KD, Connell FO, Heeran AB, Grant M, Farrell RA, Hayes C, Bracken-Clarke D, Conroy MJ, Foley E, Toole DO, Bhardwaj A, Ravi N, Reynolds JV, Maher SG, Sullivan JO, Lysaght J. Davern M, et al. Among authors: maher sg. J Cancer Res Clin Oncol. 2023 Jul;149(7):3753-3774. doi: 10.1007/s00432-022-04283-9. Epub 2022 Aug 20. J Cancer Res Clin Oncol. 2023. PMID: 35986757 Free PMC article.
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma.
Davern M, Donlon NE, O' Connell F, Sheppard AD, Hayes C, King R, Temperley H, Butler C, Bhardwaj A, Moore J, Bracken-Clarke D, Donohoe C, Ravi N, Reynolds JV, Maher SG, Conroy MJ, Lysaght J. Davern M, et al. Among authors: maher sg. Transl Oncol. 2022 Jun;20:101406. doi: 10.1016/j.tranon.2022.101406. Epub 2022 Mar 30. Transl Oncol. 2022. PMID: 35366537 Free PMC article.
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours.
Davern M, Fitzgerald MC, Buckley CE, Heeran AB, Donlon NE, McGrath J, O' Connell F, Deshpande MR, Hayes C, MacDonald J, Sheppard AD, Reynolds JV, Maher SG, Lynam-Lennon N, Murphy B, Lysaght J. Davern M, et al. Among authors: maher sg. Transl Oncol. 2022 May;19:101381. doi: 10.1016/j.tranon.2022.101381. Epub 2022 Mar 1. Transl Oncol. 2022. PMID: 35245832 Free PMC article.
PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma.
Davern M, O' Brien RM, McGrath J, Donlon NE, Melo AM, Buckley CE, Sheppard AD, Reynolds JV, Lynam-Lennon N, Maher SG, Lysaght J. Davern M, et al. Among authors: maher sg. Sci Rep. 2022 Feb 28;12(1):3259. doi: 10.1038/s41598-022-07228-x. Sci Rep. 2022. PMID: 35228614 Free PMC article.
36 results